Protease-Activated Receptors 2-Antagonist Suppresses Asthma by Inhibiting Reactive Oxygen Species-Thymic Stromal Lymphopoietin Inflammation and Epithelial Tight Junction Degradation

MLA

Ha Jung Kim, et al. “Protease-Activated Receptors 2-Antagonist Suppresses Asthma by Inhibiting Reactive Oxygen Species-Thymic Stromal Lymphopoietin Inflammation and Epithelial Tight Junction Degradation.” Allergy, Asthma & Immunology Research, vol. 11, no. 4, May 2019, pp. 560–71. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....014568e0e9e32a7749c578feb792b85d&authtype=sso&custid=ns315887.

APA

Ha Jung Kim, Soo-Jong Hong, Seung Hwa Lee, & Sekyoo Jeong. (2019). Protease-Activated Receptors 2-Antagonist Suppresses Asthma by Inhibiting Reactive Oxygen Species-Thymic Stromal Lymphopoietin Inflammation and Epithelial Tight Junction Degradation. Allergy, Asthma & Immunology Research, 11(4), 560–571.

Chicago

Ha Jung Kim, Soo-Jong Hong, Seung Hwa Lee, and Sekyoo Jeong. 2019. “Protease-Activated Receptors 2-Antagonist Suppresses Asthma by Inhibiting Reactive Oxygen Species-Thymic Stromal Lymphopoietin Inflammation and Epithelial Tight Junction Degradation.” Allergy, Asthma & Immunology Research 11 (4): 560–71. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....014568e0e9e32a7749c578feb792b85d&authtype=sso&custid=ns315887.